Document Detail


Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation.
MedLine Citation:
PMID:  15848636     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Cirrhotic patients without overt hepatic encephalopathy may have cerebral function alterations called minimal hepatic encephalopathy (MHE). Our goal was to evaluate the role of partial pressure of ammonia (pNH3), neuropsychological, and neurophysiological assessment in detecting cognitive changes in cirrhotic patients awaiting liver transplantation. MATERIALS AND METHODS: Fourteen cirrhotic patients listed for liver transplant were studied. All patients underwent the neuropsychological battery called PSE. Neurophysiological assessment including spectral EEG (sEEG), evoked potential P300 and pNH3 and venous and arterial ammonia levels was performed in all patients. Four patients were transplanted. RESULTS: Liver disease etiology was alcoholic in four patients, viral in six mixed in two, and cryptogenic in two. PSE scores revealed MHE in 8 patients; sEEG was altered in 6, and P300 in 1. No correlations were detected between P300, sEEG, and PSE. pNH3 and arterial ammonia levels were significantly higher in the subgroup of patients with altered sEEG and were correlated with theta band increase in sEEG but not with pathological PSE scores or P300 wave abnormalities. CONCLUSIONS: The combination of sEEG and PSE, and possibly also pNH3 and arterial ammonia, is useful in detecting cerebral function alterations in cirrhotic patients with no apparent encephalopathy, whereas P300 is not. The diagnosis of MHE obtained using the multimodal approach adopted in this study may enable the adequate treatment of these patients prior to surgery, which includes advising them not to drive and adjusting their priority on the waiting list for OLTx in the light of a condition that cannot be evaluated by Child Pugh score and MELD score.
Authors:
M Senzolo; P Amodio; M C D'Aloiso; S Fagiuoli; F Del Piccolo; D Canova; A Masier; M Bassanello; G Zanus; P Burra
Related Documents :
7261836 - Cholestasis and hepatic drug metabolism. comparison of metabolic clearance rate of anti...
11433896 - Are there predictive factors of severe liver fibrosis in morbidly obese patients with n...
7580786 - Spontaneous dissection of the hepatic artery.
3096806 - Development of hepatic cholestasis and fibrosis in patients with massive loss of intest...
12242736 - Gallbladder contractility in patients with cirrhotic versus malignant ascites.
23422186 - Role of diffusion-weighted imaging in early ankylosing spondylitis.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Transplantation proceedings     Volume:  37     ISSN:  0041-1345     ISO Abbreviation:  Transplant. Proc.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-04-25     Completed Date:  2005-09-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0243532     Medline TA:  Transplant Proc     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1104-7     Citation Subset:  IM    
Affiliation:
Gastroenterology, Department of Surgical and Gastroenterological Sciences, University-Hospital of Padua, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Ammonia / blood
Electroencephalography
Hepatic Encephalopathy / physiopathology*,  psychology*
Humans
Liver Cirrhosis / etiology,  physiopathology*,  psychology*
Liver Transplantation*
Neuropsychological Tests
Partial Pressure
Patient Selection
Treatment Outcome
Chemical
Reg. No./Substance:
7664-41-7/Ammonia

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Multiple organ failure caused by end-stage liver disease successfully treated with living donor live...
Next Document:  Surgical procedures for decompression of excessive shear stress in small-for-size living donor liver...